Sex hormones and risk of breast cancer in premenopausal women: A collaborative reanalysis of individual participant data from seven prospective studies

The Lancet Oncology

Volumn 14, Issue 10, 2013, Pages 1009-1019

  Key, Timothy ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTRONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER RISK; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; HUMAN; LUTEAL PHASE; PREMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; COOPERATIVE BEHAVIOR; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GONADAL STEROID HORMONES; HUMANS; PREMENOPAUSE; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN;

EID: 84883055606     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70301-2     Document Type: Article

References (39)

1. MacMahon B, Cole P, Brown J Etiology of human breast cancer: a review. J Natl Cancer Inst 1973, 50:21-42.
2. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002, 94:606-616. Endogenous Hormones and Breast Cancer Collaborative Group.
3. Kaaks R, Rinaldi S, Key TJ, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 2005, 12:1071-1082.
4. Zhang X, Tworoger SS, Eliassen AH, Hankinson SE Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up. Breast Cancer Res Treat 2013, 137:883-892.
5. Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Comstock GW Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res 1992, 52:1-4.
6. Helzlsouer KJ, Alberg AJ, Bush TL, Longcope C, Gordon GB, Comstock GW A prospective study of endogenous hormones and breast cancer. Cancer Detect Prev 1994, 18:79-85.
7. Dorgan JF, Stanczyk FZ, Kahle LL, Brinton LA Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk. Breast Cancer Res 2010, 12:R98.
8. Kaaks R, Berrino F, Key T, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005, 97:755-765.
9. Thomas HV, Key TJ, Allen DS, et al. A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. Br J Cancer 1997, 75:1075-1079.
10. Eliassen AH, Missmer SA, Tworoger SS, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006, 98:1406-1415.
11. Tworoger SS, Missmer SA, Eliassen AH, et al. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15:967-971.
12. Fortner RT, Eliassen AH, Spiegelman D, Willett WC, Barbieri RL, Hankinson SE Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Breast Cancer Res 2013, 15:R19.
13. Zeleniuch-Jacquotte A, Afanasyeva Y, Kaaks R, et al. Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast Cancer Res 2012, 14:R32.
14. Micheli A, Muti P, Secreto G, et al. Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 2004, 112:312-318.
15. Baglietto L, Severi G, English DR, et al. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010, 19:492-502.
16. Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol Biomarkers Prev 2000, 9:575-579.
17. Grant EJ, Neriishi K, Cologne J, et al. Associations of ionizing radiation and breast cancer-related serum hormone and growth factor levels in cancer-free female A-bomb survivors. Radiat Res 2011, 176:678-687.
18. Wysowski DK, Comstock GW, Helsing KJ, Lau HL Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987, 125:791-799.
19. Södergård R, Bäckström T, Shanbhag V, Carstensen H Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 1982, 16:801-810.
20. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. Cancer Epidemiol Biomarkers Prev 2003, 12:1457-1461. Endogenous Hormones and Breast Cancer Collaborative Group.
21. Key TJ, Appleby PN, Allen NE, Reeves GK Pooling biomarker data from different studies of disease risk, with a focus on endogenous hormones. Cancer Epidemiol Biomarkers Prev 2010, 19:960-965.
22. Muti P, Trevisan M, Micheli A, et al. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period. Cancer Epidemiol Biomarkers Prev 1996, 5:917-922.
23. Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 2006, 15:972-978.
24. Edman CD, MacDonald PC Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women. Am J Obstet Gynecol 1978, 130:456-461.
25. Yeung EH, Zhang C, Albert PS, et al. Adiposity and sex hormones across the menstrual cycle: the BioCycle Study. Int J Obes (Lond) 2013, 37:237-243.
26. Kopelman PG, Pilkington TR, White N, Jeffcoate SL Abnormal sex steroid secretion and binding in massively obese women. Clin Endocrinol (Oxf) 1980, 12:363-369.
27. Trichopoulos D, Cole P, Brown JB, Goldman MB, MacMahon B Estrogen profiles of primiparous and nulliparous women in Athens, Greece. J Natl Cancer Inst 1980, 65:43-46.
28. Apter D, Reinilä M, Vihko R Some endocrine characteristics of early menarche, a risk factor for breast cancer, are preserved into adulthood. Int J Cancer 1989, 44:783-787.
29. Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer 2011, 105:709-722. Endogenous Hormones and Breast Cancer Collaborative Group.
30. Mello NK Hormones, nicotine, and cocaine: clinical studies. Horm Behav 2010, 58:57-71.
31. Johnson PJ Sex hormones and the liver. Clin Sci (Lond) 1984, 66:369-376.
32. Alcohol, tobacco and breast cancer-collaborative reanalysis of individual data from 53 epidemiological studies, including 58515 women with breast cancer and 95,067 women without the disease. Br J Cancer 2002, 87:1234-1245. Collaborative Group on Hormonal Factors in Breast Cancer.
33. van den Brandt PA, Spiegelman D, Yaun SS, et al. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol 2000, 152:514-527.
34. Grodstein F, Goldman MB, Cramer DW Body mass index and ovulatory infertility. Epidemiology 1994, 5:247-250.
35. Stanczyk FZ, Lee JS, Santen RJ Standardization of steroid hormone assays: why, how, and when?. Cancer Epidemiol Biomarkers Prev 2007, 16:1713-1719.
36. Stanford JL, Hartge P, Brinton LA, Hoover RN, Brookmeyer R Factors influencing the age at natural menopause. J Chronic Dis 1987, 40:995-1002.
37. Key TJ, Pike MC The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988, 24:29-43.
38. Swerdlow AJ, Jones ME, Schoemaker MJ, et al. The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology. Br J Cancer 2011, 105:911-917.
39. Collins R What makes UK Biobank special?. Lancet 2012, 379:1173-1174.